Want to see IN:MUKKA full AI Analyst Report?
Top Page
Mukka Proteins Limited
(MUKKA)
Select Model
Select Model
Rating:56Neutral
Price Target:
₹27.00
▲(19.21% Upside)
Action:Reiterated
Date:09/06/26
The score is held back primarily by weak cash-flow fundamentals and rising debt risk despite strong revenue growth. Technicals are supportive with a strong uptrend, but momentum is stretched, increasing near-term pullback risk. Valuation is moderate based on the P/E, but lack of dividend data limits additional support.
Positive Factors
Strong revenue growth
Strong multi-year revenue expansion and the sharp 2026 rebound indicate meaningful demand for the company’s marine protein products. Continued top-line growth can improve operating scale, support reinvestment, and strengthen the business’s position with feed-industry buyers over the next several quarters.
Negative Factors
Persistent negative cash generation
Persistently negative operating and free cash flow indicate that reported profitability is not translating into internally generated funding. The resulting dependence on external capital to support expansion can reduce financial flexibility and make growth more vulnerable if funding conditions or working-capital needs worsen.
Read all positive and negative factors
Positive Factors
Negative Factors
Strong revenue growth
Strong multi-year revenue expansion and the sharp 2026 rebound indicate meaningful demand for the company’s marine protein products. Continued top-line growth can improve operating scale, support reinvestment, and strengthen the business’s position with feed-industry buyers over the next several quarters.
Read all positive factors
Mukka Proteins Limited (MUKKA) vs. iShares MSCI India ETF (INDA)
Market Cap
₹7.84B
Dividend YieldN/A
Average Volume (3M)110.43K
Price to Earnings (P/E)11.4
Beta (1Y)0.76
Revenue Growth76.01%
EPS Growth59.13%
CountryIN
Employees358
SectorGeneral
Sector StrengthN/A
IndustryPackaged Foods
Share Statistics
EPS (TTM)2.31
Shares Outstanding300,000,000
10 Day Avg. Volume28,228
30 Day Avg. Volume110,434
Financial Highlights & Ratios
PEG Ratio0.87
Price to Book (P/B)1.11
Price to Sales (P/S)0.38
P/FCF Ratio-1.86
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Mukka Proteins Limited Business Overview & Revenue Model
Company Description
Mukka Proteins Limited, based in Mangaluru, India, operates as a prominent manufacturer and supplier of protein products, extending its reach both domestically and internationally. The company specializes in a variety of fish-derived offerings, in...
How the Company Makes Money
Mukka Proteins makes money mainly by selling marine protein and lipid ingredients produced from processing fish and fish by-products. Its core revenue stream is the sale of fish meal (a high-protein ingredient used as an input in aquaculture and o...
Mukka Proteins Limited Financial Statement Overview
Summary
Income Statement
64
Positive
Balance Sheet
52
Neutral
Cash Flow
28
Negative
| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 17.70B | 14.49B | 10.06B | 13.80B | 11.56B | 7.66B |
| Gross Profit | 3.02B | 2.23B | 2.32B | 1.69B | 1.34B | 799.87M |
| EBITDA | 1.71B | 1.45B | 948.84M | 1.22B | 962.04M | 550.04M |
| Net Income | 691.27M | 520.58M | 464.59M | 700.52M | 440.75M | 242.08M |
Balance Sheet | ||||||
| Total Assets | 0.00 | 16.21B | 10.76B | 9.41B | 5.75B | 3.92B |
| Cash, Cash Equivalents and Short-Term Investments | 604.29M | 604.29M | 30.75M | 944.38M | 265.48M | 180.42M |
| Total Debt | 0.00 | 7.79B | 4.53B | 3.65B | 2.62B | 1.75B |
| Total Liabilities | -5.29B | 10.92B | 6.20B | 5.32B | 4.19B | 2.97B |
| Stockholders Equity | 5.29B | 4.99B | 4.41B | 3.96B | 1.34B | 898.23M |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -2.97B | -1.36B | -1.68B | -737.46M | -63.29M |
| Operating Cash Flow | 0.00 | -1.59B | -1.12B | -1.50B | -563.28M | 48.08M |
| Investing Cash Flow | 0.00 | -1.46B | -349.86M | -475.94M | -33.25M | -122.84M |
| Financing Cash Flow | 0.00 | 3.15B | 555.53M | 2.66B | 746.65M | 158.58M |
Mukka Proteins Limited Technical Analysis
Negative
22.65
Price Trends
26.65
Negative
24.94
Positive
23.98
Positive
Market Momentum
-0.28
Positive
44.35
Neutral
55.96
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:MUKKA, the sentiment is Negative. The current price of 22.65 is below the 20-day moving average (MA) of 27.69, below the 50-day MA of 26.65, and below the 200-day MA of 23.98, indicating a neutral trend. The MACD of -0.28 indicates Positive momentum. The RSI at 44.35 is Neutral, neither overbought nor oversold. The STOCH value of 55.96 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IN:MUKKA.
Mukka Proteins Limited Peers Comparison
UnderperformOutperform
Sector (55)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
67 Neutral | ₹249.29B | 70.46 | ― | 0.89% | 17.32% | 25.12% | |
66 Neutral | ₹95.29B | 17.47 | ― | 1.43% | 11.35% | -8.27% | |
64 Neutral | ₹38.29B | 29.07 | ― | 0.36% | 10.91% | 3.74% | |
60 Neutral | ₹10.88B | 9.79 | ― | 0.60% | 39.75% | 186.91% | |
56 Neutral | ₹7.84B | 11.37 | ― | ― | 76.01% | 59.13% | |
55 Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% | |
47 Neutral | ₹1.48B | 31.79 | ― | ― | 17.76% | -50.16% |
* General Sector Average
IN:MUKKA
Mukka Proteins Limited
26.13
-0.18
-0.68%
IN:AVANTIFEED
Avanti Feeds Limited
699.40
40.47
6.14%
IN:HATSUN
Hatsun Agro Product Limited
1,119.15
255.06
29.52%
IN:MKPL
M K Proteins Limited
3.94
-3.07
-43.79%
IN:PARAGMILK
Parag Milk Foods Ltd.
305.10
28.57
10.33%
IN:SKMEGGPROD
SKM Egg Products Export (India) Ltd.
206.70
36.84
21.69%
Mukka Proteins Limited Corporate Events
Mukka Proteins Shareholders Clear All Resolutions at 16th AGM via E-Voting
Sep 12, 2026
Mukka Proteins Limited held its 16th Annual General Meeting on September 10, 2026, via video conference in compliance with the Companies Act and relevant regulatory circulars. The company reported that all resolutions set out in the AGM notice, in...
Mukka Proteins Holds 16th AGM via Virtual Platform with Broad Shareholder Participation
Sep 10, 2026
Mukka Proteins Limited held its 16th Annual General Meeting on September 10, 2026 via video conferencing and other audio-visual means, in line with MCA and SEBI circulars. The proceedings were deemed to be conducted at the company’s register...
Mukka Proteins Extends Tenure of Independent Directors and Top Executives at AGM
Sep 10, 2026
At its 16th Annual General Meeting on 10 September 2026, Mukka Proteins Limited secured shareholder approval to reappoint three non-executive independent directors for second five-year terms commencing in January 2027. The move reinforces board co...
Mukka Proteins Wins EU Certification for Eco Sphere Organic Fertilizer
Sep 4, 2026
Mukka Proteins Limited has received an EU – Inputs Attestation from ECOCERT S.A.S., France, confirming that its Eco Sphere Organic Fertilizer is suitable for use in organic farming under specific EU programme conditions. The certification, i...
Mukka Proteins Sets Fully Virtual 16th AGM for 10 September
Aug 19, 2026
Mukka Proteins Limited has announced that its 16th Annual General Meeting will be held on 10 September 2026 at 3:00 p.m. IST through video conferencing and other audio-visual means, in line with regulatory provisions allowing virtual shareholder m...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.